Filing Details
- Accession Number:
- 0001209191-23-058994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-18 17:15:06
- Reporting Period:
- 2023-12-15
- Accepted Time:
- 2023-12-18 17:15:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790314 | B. Peter Silverman | C/O Merus N.v. Uppsalalaan 17 Utrecht P7 3584 CT | Coo & Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-12-15 | 21,100 | $0.00 | 21,100 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2023-12-15 | 1,286 | $0.00 | 22,386 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2023-12-15 | 22,386 | $25.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Share Option (right to buy) | Disposition | 2023-12-15 | 21,100 | $0.00 | 21,100 | $11.16 |
| Common Shares | Share Option (right to buy) | Disposition | 2023-12-15 | 1,286 | $0.00 | 1,286 | $12.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-20 | No | 4 | M | Direct | |
| 0 | 2030-04-16 | No | 4 | M | Direct |
Footnotes
- Represents the exercise price of the options originally granted on February 20, 2019.
- Represents the exercise price of the options originally granted on April 16, 2020.
- Amount represents the weighted average price of shares sold, which ranged from $25.02 to $25.00. Details of individual transactions are available upon request.
- Options vest over a four-year period commencing February 20, 2019. 25% vest after one year and in 36 equal monthly installments thereafter.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on February 20, 2019.
- Options vest over a four-year period commencing April 16, 2020. 25% vest after one year and in 36 equal monthly installments thereafter.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on April 20, 2020.
Billionaire Hedge Funds
